ClinicalTrials.gov
public full text
Public Domain
Cord Blood Transplantation for Patients With Cancer
The primary objective of this study is to assess the rate of engraftment with combined haploidentical-cord blood transplantation in patients with pre-existing donor specific antibodies and in those with active disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders#883033
- Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer#1096271
- Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer#805930
- Expanded Access to Provide GL-ONC1 for the Treatment of Advanced Cancers With No Standard of Care#826039
- Evaluation of Pegfilgrastim for Stem Cell Mobilization in Children#808047
Record · ID 827814
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive